{
  "id": "Ex063",
  "type": "Example",
  "informationId": {
    "id": "CritAssess339",
    "type": "CriterionAssessment",
    "criterion": {
      "id": "Crit324",
      "type": "Criterion",
      "label": "BP1",
      "description": "Missense variant in a gene for which primarily truncating variants are known to cause disease",
      "defaultStrength": {
        "id": "ELSID140",
        "type": "EvidenceLineStrength",
        "label": "Benign Supporting"
      },
      "comments": "Is there any guidance on the proportion of pathogenic variants that are LOF to apply this rule?  99%? 90%? 75%?"
    },
    "variant": {
      "id": "CanAll091",
      "type": "CanonicalAllele",
      "preferredCtxAllele": {
        "id": "CtxAll097",
        "type": "ContextualAllele",
        "producedBy": null,
        "relatedCanonicalAllele": "CanAll091",
        "alleleName": "NM_000059.3(BRCA2) :c.4779A>C"
      }
    },
    "condition": [
      {
        "id": "GenCond037",
        "type": "GeneticCondition",
        "disease": [
          {
            "id": "DisID182",
            "type": "Disease",
            "label": "Fanconi Anemia"
          }
        ]
      }
    ],
    "outcome": {
      "id": "CEID074",
      "type": "CriterionEvaluation",
      "label": "Met"
    },
    "evidenceLine": [
      {
        "id": "EvLn082",
        "type": "EvidenceLine",
        "evidenceItem": [
          {
            "id": "MolCon198",
            "type": "MolecularConsequence",
            "contextualAllele": {
              "id": "CtxAll097",
              "type": "ContextualAllele",
              "producedBy": null,
              "relatedCanonicalAllele": "CanAll091",
              "alleleName": "NM_000059.3(BRCA2) :c.4779A>C"
            },
            "consequence": {
              "id": "MCTID011",
              "type": "MolecularConsequenceType",
              "label": "missense variant"
            }
          },
          {
            "id": "Null405",
            "type": "NullAllele",
            "contextualAllele": {
              "id": "CtxAll099",
              "type": "ContextualAllele",
              "producedBy": null,
              "relatedCanonicalAllele": "CanAll093",
              "alleleName": "NM_133378.4(TTN): c.2926T>C"
            },
            "annotation": {
              "id": "NullAID224",
              "type": "NullAllele",
              "label": "No"
            }
          },
          {
            "id": "CondMech200",
            "type": "ConditionMechanism",
            "mechanism": {
              "id": "MTID071",
              "type": "MechanismType",
              "label": "loss of function variant"
            },
            "mechanismConfidence": {
              "id": "CMSID135",
              "type": "ConditionMechanismStrength",
              "label": "primary"
            },
            "gene": {
              "id": "G228",
              "type": "Gene",
              "geneSymbol": "BRCA2"
            },
            "condition": {
              "id": "GenCond037",
              "type": "GeneticCondition",
              "disease": [
                {
                  "id": "DisID182",
                  "type": "Disease",
                  "label": "Fanconi Anemia"
                }
              ]
            },
            "description": "ClinVar shows 61 variants in BRCA2 that are pathogenic for Fanconi Anemia. 55 of these (~90%) are frameshift, nonsense, or splice-site variants."
          }
        ]
      }
    ],
    "contribution": [
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent005",
          "type": "Agent",
          "label": "G. Rajar"
        },
        "contributionDate": "9/6/16 9:00 AM",
        "contributionRole": {
          "id": "CRID193",
          "type": "ContributoryRole",
          "label": "assessor role"
        }
      }
    ]
  },
  "index": 1,
  "author": "Rajarshi Ghosh",
  "description": "(same as previous - this is a compound example)\nAssessed variant: NM_000059.3(BRCA2) :c.4779A>C (p.Glu1593Asp)\nMonoallelic truncating mutations in BRCA2 confers high risk of HBOC and biallellic truncating mutations are largely responsible for Fanconi Anemia. This was identified through literature search.\nhttp://hmg.oxfordjournals.org/content/16/R1/R60.full\n Note : would be nice to have a list of genes where primarily truncating mutations results in disease."
}
